- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06321809
Intensive Lifestyle Interventions to Overweight and Obese Patients in Primary Care
January 11, 2025 updated by: Duygu Ayhan Baser
The Effect of Intensive Lifestyle Intervention Applied to Overweight and Obese Patients in Primary Care During the Pandemic Period: a Randomised Controlled Trial
The goal of this clinical trial is to compare in the effect of different lifestyle interventions in overweight and obese participants. The main questions it aims to answer are:
- effect on anthropometric measurements
- effect on lipid profile
- effect on weight-related quality of life
- observe the differences between interventions The study participants were stratified into three groups: intervention, control-1, and control-2.
- Intervention group: They were given a calorie-restricted diet and exercise plan by a dietician or physiotherapist at their first visit, and were followed up by telephone calls at weeks 2, 4, 6, 8 and 10 over 12 weeks.
- Control-1 group: During the initial medical interview, the participants were given a calorie-restricted diet programme by a dietician and an exercise programme by a physiotherapist; they were followed up over 12 weeks with telephone calls at week 4.
- Control-2 group: The participants were not provided with any programme, and the importance of weight loss was emphasised by the family physicians. Dietary and physical activity advice was given according to the recommendations in the Turkish Endocrine and Metabolism Association 2019 Obesity Diagnosis and Treatment Guide, and was followed up with phone calls at weeks 2, 4, 6, 8 and 10 over a 12-weeks.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
With this study, it is aimed to evaluate the effect of intensive lifestyle intervention to be applied to patients and follow-ups made by telephone calls in order to protect overweight and obese patients who apply to primary health care services from obesity and complications of obesity in the pandemic process in which the number of applications to secondary and tertiary care decreased due to pandemic conditions and the number of applications to primary care increased, in addition to this, the susceptibility to obesity increased due to changing lifestyle behaviours with the effect of the pandemic; The aim of this study is to evaluate the effect of intensive lifestyle intervention and telephone follow-ups on body mass index, body composition, lipid profile, obesity-related quality of life and to evaluate different forms of intervention organised as intensive lifestyle intervention and increasing the frequency of follow-up.
Study Type
Observational
Enrollment (Actual)
165
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey
- Hacettepe University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
The study's participants comprised of overweight and obese individuals who made applications to the Department of Family Medicine at XXX University's Faculty of Medicine.
Detailed information regarding the study was provided to overweight and obese individuals who applied between the dates of 25th January 2022 and 31st October 2022 and consented to participate in said study.
Description
Inclusion Criteria:
Age 18-40 BMI ≥ 25 kg/m 2 Agreeing to participate in the study Not having a diagnosed chronic disease To be able to ambulate To be cooperative
Exclusion Criteria:
- Receiving medical treatment
- Secondary obesity (hypothyroidism, Cushing's disease, etc.)
- Chronic disease (cardiovascular diseases, pulmonary diseases, presence of diabetes mellitus, liver diseases, renal diseases)
- Having hyperlipidaemia under treatment
- Cancer
- Pregnancy or breastfeeding
- Psychiatric disorder
- Orthopaedic or neurological disease that may prevent walking
- Are currently taking weight loss medication or enrolled in another weight loss program
- Having previously undergone obesity surgery or having surgery planned during the study period
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Intervention group
They were given a calorie-restricted diet and exercise plan by a dietician or physiotherapist at their first visit, and were followed up by telephone calls at weeks 2, 4, 6, 8 and 10 over 12 weeks.
|
INTENSIVE LIFESTYLE INTERVENTIONS
|
|
Control-1 group
During the initial medical interview, the participants were given a calorie-restricted diet programme by a dietician and an exercise programme by a physiotherapist; they were followed up over 12 weeks with telephone calls at week 4.
|
INTENSIVE LIFESTYLE INTERVENTIONS
|
|
Control-2 group
The participants were not provided with any programme, and the importance of weight loss was emphasised by the family physicians.
Dietary and physical activity advice was given according to the recommendations in the Turkish Endocrine and Metabolism Association 2019 Obesity Diagnosis and Treatment Guide, and was followed up with phone calls at weeks 2, 4, 6, 8 and 10 over a 12-weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Primary Outcome
Time Frame: 3 months
|
Turkish version of the Impact of Weight on Quality of Life-Lite Version (IWQOL) scale was used.
The scale has a minimum score of 0 and a maximum of 100.
The scoring system is valid for both the scale subgroups and the scale total score.
Based on the scale scoring, quality-of-life decreases as the score decreases.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Secondary
Time Frame: 3 months
|
Comparing the anthropometric measurements of the three groups at baseline and week 12.
|
3 months
|
|
BMI (kg/m2)
Time Frame: 3 months
|
Comparing the BMI of the three groups at baseline and week 12.
|
3 months
|
|
Waist Circumference (cm)
Time Frame: 3 months
|
Comparing the Waist Circumference measurements of the three groups at baseline and week 12.
|
3 months
|
|
Lipid Profile
Time Frame: 3 months
|
Lipid profile of the three groups at baseline and week 12.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Duygu Ayhan Baser, Assoc. Prof., Hacettepe University
- Principal Investigator: Dilara Canbay Ozdemir, M.D., Hacettepe University
- Principal Investigator: İzzet Fidanci, Assoc. Prof., Hacettepe University
- Principal Investigator: Arzu Demircioglu Karagoz, Hacettepe University
- Principal Investigator: Merve Ozdemir, Afyonkarahisar Health Sciences University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 25, 2022
Primary Completion (Actual)
October 1, 2022
Study Completion (Actual)
December 1, 2022
Study Registration Dates
First Submitted
March 4, 2024
First Submitted That Met QC Criteria
March 14, 2024
First Posted (Actual)
March 20, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 11, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUTF-FM-DABDCO-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on intensive lifestyle
-
The University of Hong KongSuspendedInsomnia | PreDiabetes | Sleep DeprivationHong Kong
-
Sheba Medical CenterD-Cure, Israel; Chief Scientist, The Israel Ministry of ScienceCompleted
-
Istituti Clinici Scientifici Maugeri SpAActive, not recruiting
-
Pennington Biomedical Research CenterUniversity of Alabama at Birmingham; National Institute on Minority Health... and other collaboratorsActive, not recruitingObesity | Diabetes Mellitus, Type 2 | PreDiabetesUnited States
-
Imperial College LondonLondon North West Healthcare NHS TrustCompletedType 2 DiabetesUnited Kingdom
-
Norwegian School of Sport SciencesHjelp24Completed
-
Fundacio d'Investigacio en Atencio Primaria Jordi...SCMFIC FAMILY DOCTORS CATALAN SOCIETY GRANTCompletedCardiovascular Risk FactorsSpain
-
Sheba Medical CenterCompletedObesity, ChildhoodIsrael
-
Wake Forest University Health SciencesNational Center for Advancing Translational Sciences (NCATS); W.G. Bill Hefner...WithdrawnMigraine | Migraine Disorders | Migraine Without Aura | Migraine With Aura
-
Finnish Institute for Health and WelfareUniversity of Eastern Finland; University of Oulu; Finnish Diabetes AssociationActive, not recruiting